Coronavirus Coverage

UA COVID-19 Test Tracker

Daily (12/8)
669 11 1.6%
Total (8/2)
66,070 1,065 1.6%
Includes tests since August 2, 2021
Data from https://covid19.arizona.edu/updates
Updated December 8, 2021

What 2020 has taught us

Looking back on this year, it is undeniable that people now are living through historical moments that will be recognized generation after generation. During 2020, major events such as the outbreak of COVID-19 and the months of confusion and quarantine that surrounded it have greatly affected the people and life all across the globe. University of Arizona students look back now, reflecting on the impact 2020 had on their lives.   Read more

FDA approves Pfizer's coronavirus vaccine, distribution begins

12/14/2020 1:56pm

On Friday, Dec. 11, the U.S. Food and Drug Administration issued an emergency use authorization for Pfizer/BioNTech's coronavirus vaccine as the country is currently seeing record numbers of cases, hospitalizations and deaths. This action will pave the way for millions across the U.S. to start receiving the vaccine this week.

How more time at home has sparked new interests for UA students

01/01/2021 5:19pm

When spending more time at home, students may feel the pressures of becoming isolated from the world around them and detached from their usual lifestyles. In order to combat these rising frustrations, students have been looking for new and adaptive ways to keep themselves busy during the extra time they are now presented with. This has led to the inspiration of a variety of new hobbies and interests for some University of Arizona students. 

Personalized vaccines: The new frontier in cancer treatment

12/08/2020 2:30am

Exciting results from a new clinical study showed that a personalized vaccine combined with an immunotherapy drug had a promising response rate in patients with advanced incurable head and neck cancer. Dr. Julie Bauman, chief of Hematology and Oncology at the University of Arizona College of Medicine — Tucson, led a phase one clinical trial with the pharmaceutical company, Moderna, to test the combined use of personalized vaccines created from tumor DNA with the immunotherapy drug pembrolizumab.

What you need to know about the Tucson curfew

12/05/2020 1:03pm

Tucson City Council passed an emergency curfew in an attempt to mitigate the spread of COVID-19, starting Friday Dec. 4 and will continue until Dec. 23. The curfew is in place during the hours from 10 p.m. until 5 a.m.  During the curfew hours, all persons are prohibited from using, standing, sitting, traveling, or being present on any public street or in any public place, including for the purpose of travel. 

Tips and tools for succeeding in STEM courses

12/02/2020 3:46pm

As the semester comes to an end, many may be thinking about what they would have done better to receive the grade that they wanted in a course. People work hard to achieve the grades they earn, yet the key is to identify early on what tools will be most beneficial for you.

CAJUA speaks on rapid formation, plans for the future

12/01/2020 11:33am

Last spring, 12 faculty members from the University of Arizona drafted a letter to President Dr. Robert C. Robbins and senior leadership after the university’s furlough plan came out in late April following the university’s shutdown. The letter accumulated over 2,000 signatures in support.  

Knocking down the COVID-19 disparities through university community partnerships

11/19/2020 4:57pm

The University of Arizona, in partnership with Arizona State University, Northern Arizona University and the Mayo Clinic in Scottsdale, made Arizona one of the 11 states that are participating in the National Institute of Health’s Community Engagement Alliance Against COVID-19 Disparities. With a $1 million-a-year grant, the Arizona CEAL COVID Consortium is working with over 30 community leaders and organizations to identify and combat COVID-19-related health disparities.

Moderna releases interim coronavirus vaccine data, over 94% effective

02/16/2022 10:35am

The pandemic, which has resulted in over 55 million infections and 1.3 million deaths worldwide, has started to result in major fatigue, demonstrated by daily case counts across the U.S. touching 200,000. About a week after Pfizer released early coronavirus vaccine data, Moderna — a biotechnology company based in Massachusetts — released its early results. The data shows that the vaccine is more than 94% effective.

Should professors be more lenient with assignments due to stress and anxiety?

11/12/2020 11:50am

It should come as no surprise that anxiety disorders are the most common mental illness in the United States. The Anxiety and Depression Association of America has stated that anxiety disorders are affecting approximately 40 million adults in the United States. This translates to having 18.1 percent of the United States population being diagnosed, with only 36.9 percent of that cohort receiving treatment.